Trendlines Group Ltd. · SGX:42T
Trendlines — The Trendlines Group — Investor Presentation (February 2021)
23 slides from Trendlines's investor presentation, February 2021
Slide 1: The Trendlines Group: Leaders in agrifood and medtech investment
The Trendlines Group Leaders in agrifood and medtech investment Steve Rhodes Todd Dollinger Haim Brosh Chair and CEO Chair and CEO Chief Financial Officer February 2021 SGX:42T OTCQX: TRNLY
Slide 2: Legal disclaimer
Legal disclaimer Important notice This presentation is for informational purposes only and does not constitute or form any part of any offer for sale or subscription of, or solicitation of, any offer to buy or subscribe for any securities of The Trendlines Group Ltd. (“Company”) or any of its portfo
Slide 3: Trendlines at a glance
Trendlines at a glance… Trendlines is an Israeli investment company traded on the Singapore Stock Exchange. We invest in medtech and agrifood companies directly and through our venture funds. 13 58 20 advanced-stage companies US$309M raised for portfolio years of activity active companies companies
Slide 4: Highly experienced multidisciplinary professional leadership
Highly experienced multidisciplinary professional leadership Todd Dollinger, Chair and CEO Steve Rhodes, Chair and CEO Haim Brosh, CFO Trendlines’ Founder with over 30 years of Trendlines’ Founder with over 30 years of rich Over 25 years of managerial and experience in bringing innovative products t
Slide 5: Exits: estimated returns and IRR
Exits: estimated returns and IRR Exit Company/Description Acquirer Estimated Return* IRR (%) 2020 ApiFix* OrthoPediatrics Corp. 33.9 X 68% 2017 MitrAssist Wai Tech 10.4 X 53% 2017 BioSight Arkin Bio Ventures LP 216.7 X 71% 2016 E.T.View Medical Ambu A/S 1.2 X 5% 2014 Stimatix GI* B. Braun SAS 32.3 X
Slide 6: A clear upward trend: investment - pre-exit value - exit value
A clear upward trend: investment - pre-exit value - exit value US$ millions Trendlines’ total exits as at 31 December 2020 35 33 30 Total investment by 25 Trendlines 8.7X Total pre-exit value returns 20 Trendlines’ exit value* 15 9 10 4 5 0 Trendlines' total cash investment Pre-exit value Value
Slide 7: Exit example – April 2020
Exit example – April 2020 Minimally invasive non-fusion surgical system for treating adolescent idiopathic scoliosis Founded 2011 Exit 2020 Trendlines’ added value • Invested and raised substantial capital Investors • Hired Chairman and CEO, led strategy Trendlines B. Braun • Led exit strategy • Bus
Slide 8: A taste of our agrifood companies
A taste of our agrifood companies Worlds’ first commercial grasshopper farm Early estimates of orchards and vines crop yields Artificial intelligence system using drones for agricultural pest and disease detection • Joint development with a large Israeli food • Sales in the United States, South Amer
Slide 9: Selection of promising medical device companies
Selection of promising medical device companies Digital home dialysis Enteral feeding tube directly into stomach Meniscus repair system • FDA clearance in process • FDA clearance • FDA clearance • Commercial launch expected end 2021 • Strategic investors: Germany and China • Commercial sales: U.S. &
Slide 10: Portfolio value expansion
Portfolio value expansion US$ millions Portfolio value* with exit proceeds - total US$117.8 million 140 120 Portfolio value (excluding 12 Singapore consolidated subsidiaries) 100 Cumulative exit proceeds 80 60 40 20 0 31.12.08 31.12.09 31.12.10 31.12.11 31.12.12 31.12.13 31.12.14 31.12.15 31.12.16 3
Slide 11: Our investment vehicles
Our investment vehicles Multiple and varied, suitable to the development stages of our portfolio companies, ensuring Trendlines may hold substantial equity positions Investment funds Direct investment Maryland/ Bayer Trendlines Trendlines Trendlines Trendlines Israel Trendlines Ag Agrifood Trendline
Slide 12: Full support for our companies
Full support for our companies Business development Finance Creating effective connections with Significant network investing diverse strategic customers, partners and in our portfolio companies investors accumulated Market research Ongoing in-depth tests to Technology development identify trends in
Slide 13: Investment drivers
Investment drivers 500 Team First filter opportunities a match year chemistry experience passion Initial due diligence annual Technology Market Deep due diligence differentiation need IP strength size regulation cost First investment decision Business plan risk / reward Presentation to IIA Time-to-m
Slide 14: Strategic partnerships with market leaders
Strategic partnerships with market leaders • Consensus Business Group (CBG) provides non-regulated advisory services to Librae Holdings, Trendfood, and Agriline. • Librae Holdings is Trendlines’ largest shareholder (23%) Chairman Vincent Tchenguiz • Trendfood has invested $10M in the Trendlines Agri
Slide 15: Global strategic network
Global strategic network RAU nutreco a \ AQUA BIBRAUN Consensus Srutreco he) Pan ue 4 FF BD simasseae Be" Teleflex Poros Medical ADM Forbor’ BBA @MicroPort New Protein Enterprise gterprse ACORN RLY [eraclinnovation g® NETAFIM” PRIVATE EQUITY < 47 Authority é ‘ROW MORE TALES ac my, x Oise trendlines
Slide 16: Trendlines – major shareholders
Trendlines – major shareholders Librae Holdings (holding 23% of Trendlines shares) is ultimately owned by a trust of which Vincent Tchenguiz is the discretionary beneficiary. Vincent Tchenguiz is an Iranian-British entrepreneur and businessman. In recent years, the Trust has invested some $400 milli
Slide 17: Trendlines' shareholders
Trendlines’ shareholders Librae Holdings Zeev Bronfeld 23% Amos and Daughters B. Braun Melsungen 55% Steve Rhodes & Todd Dollinger 9% Others / Public 5% 3% 5% 17
Slide 18: Balance sheet: 31 December 2020
Balance sheet: 31 December 2020 ASSETS US$'000 LIABILITIES US$'000 Current assets Current liabilities Cash and cash equivalents 10,656 Lease liability 669 Short-term bank deposits 101 Trade and other payables 1,679 Accounts and other receivables 2,698 Deferred revenues 616 2,964 Short-term loans to
Slide 19: Consolidated condensed report of income
Consolidated condensed report of income CONSOLIDATED STATEMENTS OF PROFIT OR LOSS U.S. dollars in thousands Full year ended 31 December 2020 2019 Income Gain/Loss from change in fair value of investments in Portfolio (10,996) 3,753 Companies Income from services to Portfolio Companies 2,854 4,821 In
Slide 20: Consolidated condensed report of income
Consolidated condensed report of income CONSOLIDATED STATEMENTS OF PROFIT OR LOSS U.S. dollars in thousands Full year ended 31 December 2020 2019 Expenses Operating, general and administrative expenses 7,483 7,062 Marketing expenses 214 269 R&D expenses, net 1,087 1,114 Financial expenses 860 1,240
Slide 21: Trendlines – a powerful platform for exit-oriented investments
Trendlines – a powerful platform for exit-oriented investments 20 Advanced-stage companies Exits 9 175% 8.7X exits weighted average IRR weighted average returns • Deeply experienced team • Extensive network of • Full support system for companies global strategic • Diverse investment ventures, for al
Slide 22: SGX: 42T OTCQX: TRNLY www.trendlines.com
SGX: 42T Steve Rhodes, Chair & CEO OTCQX: TRNLY steve@trendlines.com Todd Dollinger, Chair & CEO +972.72.260.7000 todd@trendlines.com www.trendlines.com Haim Brosh, Chief Financial Officer haim@trendlines.com February 2021
Slide 23: Financial Statements and Related Announcement: Full Yearly Results
FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::FULL YEARLY RESULTS Issuer & Securities Issuer/ Manager THE TRENDLINES GROUP LTD. Securities THE TRENDLINES GROUP LTD. - 1L0011328856 - 42T Stapled Security No Announcement Details Announcement Title Financial Statements and Related Announcement Date &T
The Trendlines Group — Investor Presentation (February 2021) on 6ix